# 01 — RESEARCH GATE REPORT

Date: 2026-08-07

## Decision

```text
RESEARCH FOUNDATION                 PASS
MOVE TO PHASE 2 DESIGN              AUTHORIZED
MASS CATALOG GENERATION             NOT YET AUTHORIZED
MASS CLINICAL RELATION GENERATION   NOT YET AUTHORIZED
```

## Evidence coverage

Official sources reviewed include EUR-Lex, European Commission, BOE, AESAN, EFSA, FAO/WHO, Codex Alimentarius, WHO/IUIS and a complementary public-health source (NIDDK) for clinical distinction.

## 14 EU groups

PASS. The research preserves:

- exhaustive cereals list;
- exhaustive nuts list;
- sulphite threshold;
- derivatives;
- legal exemptions;
- the mustard amendment effective from 2025-04-01.

## Extended taxonomy

PASS as an extensible model, not as a populated mass relation dataset. Official evidence confirms clinically relevant foods exist beyond EU Annex II.

## Condition taxonomy

PASS. Food allergy, food intolerance, coeliac disease and non-coeliac sensitivity are distinct. Non-medical preferences remain separate.

## Evidence policy

PASS. Every relation requires `sourceId`, `evidenceLevel`, `relationType`, `reviewedAt`. Insufficient evidence is `UNVERIFIED`.

## Language policy

PASS. Absolute safety claims are prohibited. Absence of registered matches is never displayed as proof of safety.

## Cross-contact / PAL

PASS conceptually. Direct presence, unintended cross-contact and PAL are separate. Quantitative Codex PAL logic remains outside v1 pending final-text/applicability review.

## Processing / exemptions

PASS as policy. No generic processing rule. Exemptions are case-specific and source-backed.

## Compound/commercial products

PASS as policy. Unknown composition is a first-class warning state. Manufacturer evidence is product- and date-specific.

## Open gaps

See `docs/food-safety/RESEARCH_GAPS.md`. None blocks Phase 2 design. They do block unreviewed mass relation generation.
